Transcode Therapeutics, Inc. (Nasdaq:RNAZ)
Health Care/Life Sciences • Pharmaceuticals
CIK 1829635
Company
TransCode Therapeutics, Inc. engages in the development and commercializing of diagnostics and therapeutics for the detection and treatment of cancer. The company was founded by Robert Michael Dudley, Zdravka Medarova, and Anna Moore in January 2016 and is headquartered in Boston, MA.
Address
6 Liberty Square
Suite 2382
Boston, Massachusetts 02109
6 Liberty Square
Suite 2382
Boston, Massachusetts 02109
Employees
19
19
Stock Info
Close
$0.7300
$0.7300
Day Range
0.7005 - 0.7300
0.7005 - 0.7300
52 Week Range
0.5600 - 392.0000
0.5600 - 392.0000
Average volume
569.63K
569.63K
Short Interest
220.91K (02/15/24)
220.91K (02/15/24)
% of Float Shorted
3.38%
3.38%
Market Cap
$4.6M
$4.6M
Revenue
N/A
N/A
Net Income
-$17.56M
-$17.56M
2020 Sales Growth
N/A
N/A
Key Executives
Board Of Directors
Executive Chairman Philippe P Calais PhD |
Independent Director Erik Manting PhD |
Independent Director Magda Marquet PhD |
SEC filings
Date | Form | Event |
---|---|---|
28 Aug, 2024 | 8-K | |
16 Aug, 2024 | 8-K | |
14 Aug, 2024 | 10-Q | |
26 Jul, 2024 | SC 13G | |
24 Jul, 2024 | 424B5 | |
24 Jul, 2024 | 8-K | |
22 Jul, 2024 | 424B5 | |
21 Jun, 2024 | SC 13D | |
18 Jun, 2024 | 4 | |
18 Jun, 2024 | 4 | |
18 Jun, 2024 | 4 | |
18 Jun, 2024 | 4 | |
14 Jun, 2024 | 8-K/A | |
13 Jun, 2024 | 8-K | |
10 Jun, 2024 | DEFA14A | |
7 Jun, 2024 | DEFA14A | |
7 Jun, 2024 | 8-K | |
20 May, 2024 | DEFR14A | |
15 May, 2024 | 8-K | |
15 May, 2024 | 10-Q | |
13 May, 2024 | DEFA14A | |
10 May, 2024 | PRE 14A | |
10 May, 2024 | 8-K | |
29 Apr, 2024 | ARS | |
29 Apr, 2024 | DEF 14A | |
23 Apr, 2024 | 8-K | |
5 Apr, 2024 | 8-K | |
1 Apr, 2024 | 10-K | |
15 Feb, 2024 | SC 13G/A | |
14 Feb, 2024 | SC 13G/A | |
13 Feb, 2024 | SC 13G/A | |
31 Jan, 2024 | 8-K | |
22 Jan, 2024 | 424B4 | |
22 Jan, 2024 | 8-K | |
18 Jan, 2024 | S-1/A | |
17 Jan, 2024 | CORRESP | |
17 Jan, 2024 | CORRESP | |
17 Jan, 2024 | S-1/A | |
16 Jan, 2024 | 8-K | CEO Change |
16 Jan, 2024 | UPLOAD | |
11 Jan, 2024 | S-1 | |
8 Jan, 2024 | 8-K | |
4 Jan, 2024 | DEFA14A | |
18 Dec, 2023 | DEF 14A | |
8 Dec, 2023 | 8-K | |
8 Dec, 2023 | PRE 14A | |
7 Dec, 2023 | SC 13G | |
4 Dec, 2023 | 8-K | |
1 Dec, 2023 | 424B5 | |
14 Nov, 2023 | 8-K | |
14 Nov, 2023 | 10-Q | |
9 Nov, 2023 | 8-K | |
27 Oct, 2023 | 8-K | |
26 Oct, 2023 | 424B5 | |
24 Oct, 2023 | 8-K | |
10 Oct, 2023 | SC 13D/A | |
2 Oct, 2023 | 4 | |
2 Oct, 2023 | 4 | |
28 Sep, 2023 | 8-K | |
27 Sep, 2023 | 424B4 | |
26 Sep, 2023 | SC 13G | |
25 Sep, 2023 | S-1/A | |
25 Sep, 2023 | CORRESP | |
25 Sep, 2023 | CORRESP | |
25 Sep, 2023 | CORRESP | |
25 Sep, 2023 | CORRESP | |
25 Sep, 2023 | EFFECT | |
22 Sep, 2023 | CORRESP | |
22 Sep, 2023 | CORRESP | |
22 Sep, 2023 | CORRESP | |
15 Sep, 2023 | CORRESP | |
15 Sep, 2023 | CORRESP | |
11 Sep, 2023 | S-1/A | |
31 Aug, 2023 | UPLOAD | |
29 Aug, 2023 | S-1 | |
24 Aug, 2023 | 8-K | |
14 Aug, 2023 | 10-Q | |
4 Aug, 2023 | 8-K | |
28 Jul, 2023 | 8-K | |
22 Jun, 2023 | 4 | |
16 Jun, 2023 | SC 13D/A | |
14 Jun, 2023 | 4/A | |
13 Jun, 2023 | 4 | |
8 Jun, 2023 | 8-K | |
7 Jun, 2023 | 424B4 | |
6 Jun, 2023 | EFFECT | |
6 Jun, 2023 | CORRESP | |
6 Jun, 2023 | S-1/A | |
5 Jun, 2023 | S-1/A | |
5 Jun, 2023 | CORRESP | |
25 May, 2023 | UPLOAD | |
22 May, 2023 | 8-K | |
19 May, 2023 | 4 | |
19 May, 2023 | 8-K | |
19 May, 2023 | S-1 | |
19 May, 2023 | 4 | |
19 May, 2023 | 4 | |
19 May, 2023 | 4 | |
19 May, 2023 | 4 | |
18 May, 2023 | 8-K | |
15 May, 2023 | 10-Q | |
10 May, 2023 | 4 | |
10 May, 2023 | 4 | |
10 May, 2023 | 4 | |
10 May, 2023 | 8-K | |
14 Apr, 2023 | 8-K | |
14 Apr, 2023 | 424B5 | |
10 Apr, 2023 | DEF 14A | |
10 Apr, 2023 | ARS | |
31 Mar, 2023 | 10-K | |
31 Mar, 2023 | 8-K | |
31 Mar, 2023 | 8-K | |
31 Mar, 2023 | PRE 14A | |
17 Feb, 2023 | 8-K | |
17 Feb, 2023 | 424B5 | |
14 Feb, 2023 | RW | |
10 Feb, 2023 | SC 13G/A | |
1 Feb, 2023 | S-1 | |
1 Feb, 2023 | 8-K | |
20 Dec, 2022 | SC 13G | |
20 Dec, 2022 | SC 13D | |
20 Dec, 2022 | SC 13G | |
16 Dec, 2022 | EFFECT | |
14 Dec, 2022 | 4 | |
14 Dec, 2022 | UPLOAD | |
14 Dec, 2022 | 4 | |
14 Dec, 2022 | 4 | |
14 Dec, 2022 | CORRESP | |
14 Dec, 2022 | 4 | |
13 Dec, 2022 | S-3 | |
9 Dec, 2022 | 8-K | |
6 Dec, 2022 | RW | |
30 Nov, 2022 | S-1/A | |
30 Nov, 2022 | 8-K | |
28 Nov, 2022 | S-1 | |
14 Nov, 2022 | 10-Q | |
14 Nov, 2022 | 8-K | |
27 Oct, 2022 | SC 13G/A | |
16 Sep, 2022 | 4 | |
15 Aug, 2022 | 10-Q | |
15 Aug, 2022 | 8-K | |
3 Aug, 2022 | 8-K | |
29 Jul, 2022 | DRS | |
23 Jun, 2022 | 8-K | |
22 Jun, 2022 | 4 | |
22 Jun, 2022 | 4 | |
22 Jun, 2022 | 4 | |
17 Jun, 2022 | 4 | |
9 Jun, 2022 | S-8 | |
1 Jun, 2022 | 4 | |
16 May, 2022 | 8-K | |
16 May, 2022 | 10-Q | |
2 May, 2022 | DEFA14A | |
2 May, 2022 | DEF 14A | |
1 Apr, 2022 | 8-K | |
31 Mar, 2022 | 10-K | |
2 Mar, 2022 | 4 | |
11 Feb, 2022 | SC 13G/A | |
3 Feb, 2022 | 4 | |
3 Feb, 2022 | 4 | |
15 Nov, 2021 | 8-K | |
15 Nov, 2021 | 10-Q | |
30 Sep, 2021 | 8-K | |
23 Aug, 2021 | 8-K | |
23 Aug, 2021 | 10-Q | |
21 Jul, 2021 | SC 13G | |
13 Jul, 2021 | S-8 | |
13 Jul, 2021 | 8-K | |
9 Jul, 2021 | 424B4 | IPO completed |
8 Jul, 2021 | 3 | |
8 Jul, 2021 | SEC STAFF | |
8 Jul, 2021 | EFFECT | |
8 Jul, 2021 | 3 | |
8 Jul, 2021 | 3 | |
8 Jul, 2021 | 3 | |
8 Jul, 2021 | 3 | |
8 Jul, 2021 | 3 | |
8 Jul, 2021 | 3 | |
6 Jul, 2021 | CORRESP | |
6 Jul, 2021 | CORRESP | |
2 Jun, 2021 | S-1/A | |
1 Jun, 2021 | CORRESP | |
14 May, 2021 | CORRESP | |
6 May, 2021 | CORRESP | |
6 May, 2021 | CORRESP | |
3 May, 2021 | S-1/A | |
27 Apr, 2021 | CERT | |
26 Apr, 2021 | 8-A12B | |
23 Apr, 2021 | CORRESP | |
23 Apr, 2021 | CORRESP | |
16 Apr, 2021 | S-1/A | |
16 Apr, 2021 | CORRESP | |
14 Apr, 2021 | UPLOAD | |
8 Apr, 2021 | S-1/A | |
24 Mar, 2021 | S-1/A | |
11 Mar, 2021 | CORRESP | |
26 Feb, 2021 | S-1 | |
28 Jan, 2021 | SEC STAFF | |
27 Jan, 2021 | DRS/A | |
27 Jan, 2021 | DRSLTR | |
15 Jan, 2021 | UPLOAD | |
18 Dec, 2020 | DRS |
Last update:2024-03-08 12:05:14.951570
Sign Up to Subscribe
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.